UKIPO trademark

OYSTER THERAPEUTICS

FiledUKIPOWord markClass 1Class 5Class 9Class 42+1

"OYSTER THERAPEUTICS" is a word mark owned by Kesmalea Therapeutics Limited, filed at the UKIPO on October 12, 2026. It is filed and waiting for examination and covers classes 1, 5, 9, 42 and 44.

Get this data via the API
Official UKIPO record
OYSTER THERAPEUTICS
Word mark as filed with the UKIPO
Status
Filed
Since October 12, 2026
Filed
October 12, 2026
Registered
Not yet
Expires
Not recorded
Application no.
UK00004458815
Registration no.
UK00004458815
Office
UKIPO
Intellectual Property Office
Mark type
Word mark
5 classes
Ownership

Who owns OYSTER THERAPEUTICS

The owner and representative on file with the office.

Owner

Kesmalea Therapeutics Limited

United Kingdom

Representative

CMS Cameron McKenna Nabarro Olswang LLP

CMS Cameron McKenna Nabarro Olswang LLP

Goods and services

What the mark covers

The products and services OYSTER THERAPEUTICS is filed for, grouped by Nice class.

  • Proteins for use in science; regulatory proteins for scientific and medical use; chemical reagents for use in biotechnology, other than for medical or veterinary use.

  • Pharmaceutical preparations; pharmaceutical preparations, in particular, chemical and biological preparations for medical purposes; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment or prevention of disorders or diseases caused by bacteria; biological preparations for the treatment of cancer; biological preparations for the treatment of viral infections; biological preparations for the treatment of autoimmune diseases; biological preparations for the treatment of central nervous system diseases; biological preparations for medical use; immunotherapeutic drugs; reagents for medical use; diagnostic preparations; diagnostic reagents for medical use; protein synthesis inhibitors.

  • Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signalling, detecting, testing, inspecting, life-saving and teaching apparatus and instruments; software; software for use in scientific and/or pharmaceutical research and development; software for scientific modelling; software for pharmaceutical modelling; software for research and development in the field of oncology, immunology and central nervous system disease; software for the managing, analysis, and visualisation of biological data; devices for analysing protein sequence used as laboratory apparatus.

  • Scientific, medical and technological services and research and design relating thereto; research relating to molecular sciences; analysis in the field of molecular biology; drug discovery services; clinical research; medical research; biological research; research relating to pharmaceuticals; pharmaceutical research and development; development of pharmaceutical preparations and medicines; platform as a service [PaaS]; platform as a service [PaaS] featuring medical analysis software; software as a service [Saas]; software as a service [Saas] featuring medical analysis software; provision of non-downloadable software for the management, visualisation and analysis of biological data for the purposes of biomolecular research and the design and engineering of biomolecular products; biotechnology research; biotechnology testing; research and development in the pharmaceutical and biotechnology fields; scientific screening and assaying; chemical analysis; chemical research; medical research in the field of oncology, immunology and central nervous system diseases; research and development in the field of protein homeostasis; clinical trials.

  • Medical services; medical analysis services; oral medical care services; medical diagnostic services; diagnostic and prognostic medical services; advisory services relating to medical services; medical screening and assaying; medical services in the field of oncology and immunotherapy; pharmacy advice; medical and health services relating to antibodies, immuno-oncology, inflammation, haematology, central nervous system and infectious disease; medical screening and assaying.

FAQ

About OYSTER THERAPEUTICS

Who owns the trademark "OYSTER THERAPEUTICS"?

The UKIPO trademark "OYSTER THERAPEUTICS" (application UK00004458815) is owned by Kesmalea Therapeutics Limited.

What is the status of "OYSTER THERAPEUTICS"?

Its status at the UKIPO is: filed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull OYSTER THERAPEUTICS and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a13353-32ff-7383-8b2d-c75cd5f48e7a
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a13353-32ff-7383-8b2d-c75cd5f48e7a",
  "object": "trademark",
  "mark_text": "OYSTER THERAPEUTICS",
  "status": {
    "primary": "pending",
    "stage": "filed"
  },
  "office_code": "GB",
  "application_number": "UK00004458815",
  "filing_date": "2026-10-12",
  "nice_classes": [
    1,
    5,
    9,
    42,
    44
  ],
  "owners": [
    {
      "name": "Kesmalea Therapeutics Limited",
      "entity_id": null
    }
  ]
}